SCB-2019
candidate vaccine against COVID-19
Facts
7 properties- Instance of
- funded product, vaccine type[2]
- Subclass of
- protein subunit vaccine, vaccine candidate[6][7]
- Described by source
- A Phase 1 Study of SCB-2019 for COVID-19 in Healthy Volunteers, Biomimetic nanovaccines for COVID-19[8][9]
- Manufacturer
- Clover Biopharmaceuticals Inc.[3]
🏷️ Also known as
en Clover Biopharmaceuticals Inc. COVID-19 vaccine candidate
en SCB-2019
🔗 Connections
Developer 1
Vaccine for 1
Press Enter · cited answer in seconds
0 sources
Summary
SCB-2019 is a funded product[1].